New combo radiation approach aims to control advanced lung cancer

NCT ID NCT07565987

Recruiting now Disease control Sponsor: All India Institute of Medical Sciences Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving high-precision radiation (SBRT) to the main tumor and nearby lymph nodes, along with standard chemotherapy, can better control stage III non-small cell lung cancer. The trial will enroll 20 adults whose tumors are less than 6 cm and who have not spread to other organs. Researchers will track how long the cancer stays under control and any side effects over two years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Stereotactic body radiotherapy (SBRT) – high-precision radiation to the tumor and lymph nodes
What this could lead to: If successful, this could show that combining SBRT with chemotherapy improves local control and survival for stage III lung cancer patients.
What could go wrong: This is a small, early-phase trial with only 20 participants, so results may not apply broadly. There is also a risk of radiation-related side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CANCER

Contacts and locations

Locations

Nci, Aiims-Jhajjar
RECRUITING

Jhajjar, Haryana, 124105, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.